Glycolytic regulation of cell rearrangement in angiogenesis

Nature Communications

Volumn 7, Issue , 2016, Pages

  Cruys, Bert ^a,b   Wong, Brian W ^a,b   Kuchnio, Anna ^a,b   Verdegem, Dries ^a,b   Cantelmo, Anna Rita ^a,b   Conradi, Lena Christin ^a,b   Vandekeere, Saar ^a,b   Bouche, Ann ^a,b   Cornelissen, Ivo ^a,b   Vinckier, Stefan ^a,b   Merks, Roeland M H ^c,d   Dejana, Elisabetta ^e,f,g   Gerhardt, Holger ^a,h,i   Dewerchin, Mieke ^a,b   Bentley, Katie ^e,j   Carmeliet, Peter ^a,b  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b Laboratory of Angiogenesis and Neurovascular Link   (Belgium)

^c CWI   (Netherlands)

^d LEIDEN UNIVERSITY   (Netherlands)

^e UPPSALA UNIVERSITY   (Sweden)

^f FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

^h DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

ⁱ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^j HARVARD MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE FRUCTOSE 2,6 BISPHOSPHATASE 3; ADENOSINE TRIPHOSPHATE; FRUCTOSE 2,6 BISPHOSPHATASE; UNCLASSIFIED DRUG; VASCULOTROPIN; 3-(3-PYRIDINYL)-1-(4-PYRIDINYL)-2-PROPEN-1-ONE; 6 PHOSPHOFRUCTO 2 KINASE; CADHERIN; INDOLE DERIVATIVE; LEUKOCYTE ANTIGEN; PYRIDINE DERIVATIVE; PYRROLE DERIVATIVE; SEMAXANIB; VASCULAR ENDOTHELIAL CADHERIN; VASCULOTROPIN A;

CANCER; CELL ORGANELLE; COMPUTER SIMULATION; DISEASE TREATMENT; EXPERIMENTAL STUDY; GENE; GENETIC ANALYSIS; METABOLISM; PATHOLOGY;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELLULAR DISTRIBUTION; COMPUTER MODEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME INHIBITION; FILOPODIUM; GLYCOLYSIS; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PREDICTION; REGULATORY MECHANISM; SIMULATION; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; COMPUTER SIMULATION; DRUG EFFECT; GENE KNOCKDOWN; METABOLISM; PSEUDOPODIUM; UMBILICAL VEIN ENDOTHELIAL CELL;

ADENOSINE TRIPHOSPHATE; ANTIGENS, CD; CADHERINS; COMPUTER SIMULATION; GENE KNOCKDOWN TECHNIQUES; GLYCOLYSIS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INDOLES; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOFRUCTOKINASE-2; PSEUDOPODIA; PYRIDINES; PYRROLES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84979523593     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms12240     Document Type: Article

References (47)

1. Phng, L. K. & Gerhardt, H. Angiogenesis: a team effort coordinated by notch. Dev. Cell 16, 196-208 (2009).
2. Potente, M., Gerhardt, H. & Carmeliet, P. Basic and therapeutic aspects of angiogenesis. Cell 146, 873-887 (2011).
3. Arima, S. et al. Angiogenic morphogenesis driven by dynamic and heterogeneous collective endothelial cell movement. Development 138, 4763-4776 (2011).
4. Jakobsson, L. et al. Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting. Nat. Cell Biol. 12, 943-953 (2010).
5. De Bock, K. et al. Role of PFKFB3-driven glycolysis in vessel sprouting. Cell 154, 651-663 (2013).
6. Schoors, S. et al. Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis. Cell Metab 19, 37-48 (2014).
7. Xu, Y. et al. Endothelial PFKFB3 plays a critical role in angiogenesis. Arterioscler. Thromb. Vasc. Biol. 34, 1231-1239 (2014).
8. Schoors, S. et al. Incomplete and transitory decrease of glycolysis: a new paradigm for anti-angiogenic therapy? Cell Cycle 13, 16-22 (2014).
9. Bentley, K. et al. The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis. Nat. Cell Biol. 16, 309-321 (2014).
10. Gavard, J. & Gutkind, J. S. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat. Cell Biol. 8, 1223-1234 (2006).
11. Eelen, G., Cruys, B., Welti, J., De Bock, K. & Carmeliet, P. Control of vessel sprouting by genetic and metabolic determinants. Trends Endocrinol. Metab. 24, 589-596 (2013).
12. Sauteur, L. et al. Cdh5/VE-cadherin promotes endothelial cell interface elongation via cortical actin polymerization during angiogenic sprouting. Cell Rep. 9, 504-513 (2014).
13. Le Clainche, C. & Carlier, M. F. Regulation of actin assembly associated with protrusion and adhesion in cell migration. Physiol. Rev. 88, 489-513 (2008).
14. Bernstein, B. W. & Bamburg, J. R. Actin-ATP hydrolysis is a major energy drain for neurons. J. Neurosci. 23, 1-6 (2003).
15. Daniel, J. L., Molish, I. R., Robkin, L. & Holmsen, H. Nucleotide exchange between cytosolic ATP and F-actin-bound ADP may be a major energyutilizing process in unstimulated platelets. Eur. J. Biochem. 156, 677-684 (1986).
16. Moreno, V. et al. An EMMPRIN-gamma-catenin-Nm23 complex drives ATP production and actomyosin contractility at endothelial junctions. J. Cell Sci. 127, 3768-3781 (2014).
17. Troyanovsky, R. B., Sokolov, E. P. & Troyanovsky, S. M. Endocytosis of cadherin from intracellular junctions is the driving force for cadherin adhesive dimer disassembly. Mol. Biol. Cell 17, 3484-3493 (2006).
18. Izumi, G. et al. Endocytosis of E-cadherin regulated by Rac and Cdc42 small G proteins through IQGAP1 and actin filaments. J. Cell Biol. 166, 237-248 (2004).
19. George, S. K., Meyer, T. N., Abdeen, O., Bush, K. T. & Nigam, S. K. Tunicamycin preserves intercellular junctions, cytoarchitecture, and cell-substratum interactions in ATP-depleted epithelial cells. Biochem. Biophys. Res. Commun. 322, 223-231 (2004).
20. Bacallao, R., Garfinkel, A., Monke, S., Zampighi, G. & Mandel, L. J. ATP depletion: a novel method to study junctional properties in epithelial tissues. I. Rearrangement of the actin cytoskeleton. J. Cell Sci. 107, 3301-3313 (1994).
21. Bentley, K., Jones, M. & Cruys, B. Predicting the future: towards symbiotic computational and experimental angiogenesis research. Exp. Cell Res. 319, 1240-1246 (2013).
22. Bentley, K., Gerhardt, H. & Bates, P. A. Agent-based simulation of notch-mediated tip cell selection in angiogenic sprout initialisation. J. Theor. Biol. 250, 25-36 (2008).
23. Gerhardt, H. et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J. Cell Biol. 161, 1163-1177 (2003).
24. Bentley, K., Mariggi, G., Gerhardt, H. & Bates, P. A. Tipping the balance: robustness of tip cell selection, migration and fusion in angiogenesis. PLoS Comput. Biol. 5, e1000549 (2009).
25. Bentley, K., Harrington, K. & Regan, E. R. Can active perception generate bistability? Heterogeneous collective dynamics and vascular patterning. In Proceedings of the Fourteenth International Conference on the Synthesis and Simulation of Living Systems 14, 328-335 (2014).
26. Bentley, K., Philippides, A. & Ravasz Regan, E. Do endothelial cells dream of eclectic shape? Dev. Cell 29, 146-158 (2014).
27. Graner, F. Glazier JA. Simulation of biological cell sorting using a twodimensional extended Potts model. Phys. Rev. Lett. 69, 2013-2016 (1992).
28. Ubezio, B. et al. Synchronization of endothelial Dll4-Notch dynamics switch blood vessels from branching to expansion. Elife 5 (2016).
29. Finley, S. D. & Popel, A. S. Effect of tumor microenvironment on tumor VEGF during anti-VEGF treatment: systems biology predictions. J. Natl Cancer Inst. 105, 802-811 (2013).
30. Xu, Z. Q. et al. EZH2 promotes tumor progression by increasing VEGF expression in clear cell renal cell carcinoma. Clin. Transl. Oncol. 17, 41-49 (2015).
31. Li, L. et al. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Anticancer Res. 24, 1973-1979 (2004).
32. Matsuyama, W. et al. Serum levels of vascular endothelial growth factor dependent on the stage progression of lung cancer. Chest 118, 948-951 (2000).
33. Choi, J. A., Hwang, J. U., Yoon, Y. H. & Koh, J. Y. Methallothionein-3 contributes to vascular endothelial growth factor induction in a mouse model of choroidal neovascularization. Metallomics 5, 1387-1396 (2013).
34. Fong, T. A. et al. SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types. Cancer Res. 59, 99-106 (1999).
35. Sawada, J. et al. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer Cell 22, 235-249 (2012).
36. Carmeliet, P. & Jain, R. K. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat. Rev. Drug Discov. 10, 417-427 (2011).
37. Li, X. et al. VEGFR2 pY949 signalling regulates adherens junction integrity and metastatic spread. Nat. Commun. 7, 11017 (2016).
38. Peirce, S. M. Computational and mathematical modeling of angiogenesis. Microcirculation 15, 739-751 (2008).
39. Vestweber, D., Winderlich, M., Cagna, G. & Nottebaum, A. F. Cell adhesion dynamics at endothelial junctions: VE-cadherin as a major player. Trends Cell Biol. 19, 8-15 (2009).
40. Schnittler, H. et al. Actin filament dynamics and endothelial cell junctions: the Ying and Yang between stabilization and motion. Cell Tissue Res. 355, 529-543 (2014).
41. Kaksonen, M., Toret, C. P. & Drubin, D. G. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell Biol. 7, 404-414 (2006).
42. Jain, R. K. Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26, 605-622 (2014).
43. Bravi, L., Dejana, E. & Lampugnani, M. G. VE-cadherin at a glance. Cell Tissue Res. 355, 515-522 (2014).
44. Jaffe, E. A., Hoyer, L. W. & Nachman, R. L. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J. Clin. Invest. 52, 2757-2764 (1973).
45. Carlotti, F. et al. Lentiviral vectors efficiently transduce quiescent mature 3T3-L1 adipocytes. Mol. Ther. 9, 209-217 (2004).
46. Korff, T., Krauss, T. & Augustin, H. G. Three-dimensional spheroidal culture of cytotrophoblast cells mimics the phenotype and differentiation of cytotrophoblasts from normal and preeclamptic pregnancies. Exp. Cell Res. 297, 415-423 (2004).
47. Seaman, M. E., Peirce, S. M. & Kelly, K. Rapid analysis of vessel elements (RAVE): a tool for studying physiologic, pathologic and tumor angiogenesis. PLoS ONE 6, e20807 (2011).